Chris Wealth Management

Zee Ent board approves Rs 2,000 crore fund raising via shares 

This fund manager with over Rs 350 cr in AUM generates 2x returns vs benchmark since June 2023

London stocks edge up in anticipation of ECB rate cut

Were exit polls rigged to manipulate stock market? MP seeks Sebi investigation

Tokyo shares close higher

Orchid Pharma receives DCGI approval for its first invented and made-in-antibiotic Drug combination of Cefepime and Enmetazobactam (NCE)

Buzzing: BHEL jumps over 14% after winning thermal power project orders

Nifty, midcap, and smallcap above pre-exit poll level

Indian bond yields dip as focus moves to US yields

Aimtron Electronics shares debut at a premium of 50% on NSE SME platform 

FII/DII Tracker

Rejection trades set in on reaching 22600 as outlined yesterday. Even though we were poised to see an outright turn lower, the pattern so far has been structured enough to allow an extension in the uptrend aiming 22900 or more. Meanwhile, it is fair to expect a pause or pull back initially, but support formation at 22520, 22400 and finally 22230 assures that a directional downside may have to wait.

BHEL surged by hitting a 10% upper circuit after securing orders for thermal power projects, notably from Adani Power.